Broadfin Capital, LLC historic quarter change: USA Stocks, New
In share positions in stocks (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, Broadfin Capital, LLC opened 26 positions, added to 33, reduced 48 and sold out of 30.
- Q3 2016: Stock TRUP; Country of operation United States; Class COM; Shares before 0.
- Q2 2016: Stock PCRX; Country of operation United States; Class COM; Shares before 0.
- Q3 2015: Stock MASI; Country of operation United States; Class COM; Shares before 0.
- Q2 2015: Stock ARDX; Country of operation United States; Class COM; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1511901), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2010-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | TRUP
TRUPANION INC | United States | COM | 0 | 158,600 | +158,600 | $0 | $2,680,000 | +$2,680,000 | 2016-11-14 |
|---|
| Q2 2016 | PCRX
PACIRA PHARMACEUTICALS INC | United States | COM | 0 | 93,380 | +93,380 | $0 | $3,150,000 | +$3,150,000 | 2016-08-15 |
|---|
| Q3 2015 | MASI
MASIMO ORD | United States | COM | 0 | 421,728 | +421,728 | $0 | $16,262,000 | +$16,262,000 | 2015-11-16 |
|---|
| Q2 2015 | ARDX
ARDELYX INC | United States | COM | 0 | 649,290 | +649,290 | $0 | $8,877,000 | +$8,877,000 | 2015-08-14 |
|---|
| Q2 2015 | VCYT
VERACYTE INC | United States | COM | 0 | 736,196 | +736,196 | $0 | $8,201,000 | +$8,201,000 | 2015-08-14 |
|---|
| Q2 2015 | COLL
COLLEGIUM PHARMACEUTICAL INC | United States | COM | 0 | 297,200 | +297,200 | $0 | $5,302,000 | +$5,302,000 | 2015-08-14 |
|---|
| Q1 2015 | FATE
FATE THERAPEUTICS INC | United States | COM | 0 | 70,428 | +70,428 | $0 | $344,000 | +$344,000 | 2015-05-15 |
|---|
| Q1 2015 | OSUR
ORASURE TECHNOLOGIES INC | United States | COM | 0 | 50,000 | +50,000 | $0 | $327,000 | +$327,000 | 2015-05-15 |
|---|
| Q4 2014 | DVAX
DYNAVAX TECHNOLOGIES CORP | United States | COM NEW | 0 | 766,010 | +766,010 | $0 | $12,915,000 | +$12,915,000 | 2015-02-17 |
|---|
| Q4 2014 | LGND
LIGAND PHARMACEUTICALS INC | United States | COM NEW | 0 | 199,000 | +199,000 | $0 | $10,589,000 | +$10,589,000 | 2015-02-17 |
|---|
| Q4 2014 | ADMA
ADMA BIOLOGICS INC | United States | COM | 0 | 389,193 | +389,193 | $0 | $4,347,000 | +$4,347,000 | 2015-02-17 |
|---|
| Q4 2014 | MASI
MASIMO CORP | United States | COM | 0 | 97,900 | +97,900 | $0 | $2,579,000 | +$2,579,000 | 2015-02-17 |
|---|
| Q3 2014 | AMPH
AMPHASTAR PHARMACEUTICALS IN | United States | COM | 0 | 1,977,854 | +1,977,854 | $0 | $23,042,000 | +$23,042,000 | 2014-11-14 |
|---|
| Q3 2014 | INFIQ
INFINITY PHARMACEUTICALS INC | United States | COM | 0 | 854,384 | +854,384 | $0 | $11,466,000 | +$11,466,000 | 2014-11-14 |
|---|
| Q3 2014 | CNMD
CONMED CORP | United States | COM | 0 | 150,000 | +150,000 | $0 | $5,526,000 | +$5,526,000 | 2014-11-14 |
|---|
| Q3 2014 | ARAY
ACCURAY INC | United States | COM | 0 | 500,000 | +500,000 | $0 | $3,630,000 | +$3,630,000 | 2014-11-14 |
|---|
| Q3 2014 | IRMD
IRADIMED CORP | United States | COM | 0 | 410,884 | +410,884 | $0 | $2,880,000 | +$2,880,000 | 2014-11-14 |
|---|
| Q2 2014 | BKD
BROOKDALE SR LIVING INC | United States | COM | 0 | 303,000 | +303,000 | $0 | $10,102,000 | +$10,102,000 | 2014-08-14 |
|---|
| Q2 2014 | CPRX
CATALYST PHARM PARTNERS INC | United States | COM | 0 | 2,400,000 | +2,400,000 | $0 | $6,072,000 | +$6,072,000 | 2014-08-14 |
|---|
| Q2 2014 | HAE
HAEMONETICS CORP | United States | COM | 0 | 3,600 | +3,600 | $0 | $127,000 | +$127,000 | 2014-08-14 |
|---|
| Q1 2014 | HRTX
HERON THERAPEUTICS INC | United States | COM | 0 | 2,233,173 | +2,233,173 | $0 | $31,063,000 | +$31,063,000 | 2014-05-15 |
|---|
| Q1 2014 | OMER
OMEROS CORP | United States | COM | 0 | 300,000 | +300,000 | $0 | $3,621,000 | +$3,621,000 | 2014-05-15 |
|---|
| Q4 2013 | SRPT
SAREPTA THERAPEUTICS INC | United States | COM | 0 | 726,655 | +726,655 | $0 | $14,801,000 | +$14,801,000 | 2014-02-28 |
|---|
| Q4 2013 | XNCR
XENCOR INC | United States | COM | 0 | 874,000 | +874,000 | $0 | $7,988,000 | +$7,988,000 | 2014-02-28 |
|---|
| Q4 2013 | MOH
MOLINA HEALTHCARE INC | United States | COM | 0 | 229,300 | +229,300 | $0 | $7,968,000 | +$7,968,000 | 2014-02-28 |
|---|
| Q3 2013 | DGX
QUEST DIAGNOSTICS INC | United States | COM | 0 | 25,000 | +25,000 | $0 | $1,545,000 | +$1,545,000 | 2013-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |